Omaxe quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	576	321	+79.4%
EBITDA	0.4	−169	—
EBITDA margin	0.1%	−52.7%	+52.8 pts
Profit before tax	−7.1	−216	—
Net profit	−25.6	−166	—
EPS	−₹1.37	−₹9.11	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	576	406	349	302	321	282	541	289	389	342	536	599	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	38.4	32.8	27.8	17.2	25.5	15.8	11.8	11.5	9.1	43.6	6.7	2.7
	614	439	376	319	346	298	553	300	398	385	542	602
	695	523	778	757	819	458	514	642	576	365	448	409
	−167	−151	−299	−337	−372	−41.4	88.2	−269	−5.0	100	180	186
	4.5	2.8	5.5	3.9	7.3	7.9	6.6	5.3	6.3	5.9	5.3	9.4
	36.6	27.1	69.5	53.9	64.7	67.0	51.3	57.0	44.6	42.4	38.2	32.4
	9.3	7.9	10.1	9.0	8.3	7.2	11.6	10.4	7.5	7.2	13.6	14.6
	42.4	23.6	66.3	33.6	35.3	27.7	38.6	38.0	35.7	21.6	48.8	32.9
	621	434	630	520	563	526	710	483	665	542	734	684
	0.4	7.3	−202	−155	−169	−170	−106	−127	−224	−151	−146	−37.4
	−8.9	−0.6	−212	−164	−177	−177	−118	−137	−231	−158	−160	−52.0
Profit
	−7.1	5.1	−254	−201	−216	−228	−157	−183	−267	−157	−191	−81.8
	−7.1	5.1	−254	−201	−216	−228	−157	−183	−267	−157	−191	−81.8
	5.5	2.5	0.6	0.7	1.2	1.1	−2.6	1.8	2.1	1.4	0.3	1.5
	13.0	1.3	−62.9	−48.3	−51.2	−43.4	−6.0	−34.2	−29.6	−11.5	−47.9	−11.4
	18.5	3.8	−62.3	−47.6	−50.0	−42.3	−8.6	−32.4	−27.5	−10.2	−47.6	−9.9
	0.0	0.0	−0.0	0.0	0.0	0.0	−0.1	0.0	−0.2	0.0	0.1	0.1
	−25.6	1.3	−191	−153	−166	−186	−149	−150	−239	−147	−144	−71.8
	−25.6	1.3	−191	−153	−166	−186	−149	−150	−239	−147	−144	−71.8
	1.2	−0.3	0.1	−0.1	0.0	0.5	0.8	0.5	0.4	−1.3	0.2	0.1
	−24.4	1.1	−191	−153	−166	−185	−148	−150	−239	−148	−143	−71.7
	—	0.9	−191	−153	−167	—	−148	−151	−240	−147	−145	—
	—	0.4	−0.1	0.0	0.2	—	−0.4	0.3	0.2	0.5	1.5	0.0
Per share
	−₹1.37	₹0.05	−₹10.46	−₹8.38	−₹9.11	−₹10.16	−₹8.11	−₹8.23	−₹13.10	−₹8.06	−₹7.93	−₹3.66
	−₹1.37	₹0.05	−₹10.46	−₹8.38	−₹9.11	−₹10.16	−₹8.11	−₹8.23	−₹13.10	−₹8.06	−₹7.93	−₹3.66
Other comprehensive income — detail
	1.2	−0.3	0.1	−0.1	0.0	0.5	0.8	—	—	—	—	—
	1.6	−0.3	0.5	−0.1	0.1	0.6	0.9	0.7	0.4	−1.7	0.3	0.1
	0.4	−0.1	0.5	−0.0	0.1	0.2	0.1	—	—	—	—	—
	—	—	—	—	—	—	—	0.2	0.0	−0.4	0.1	0.0
	—	0.6	−191	−153	—	—	−148	−150	−239	−149	−145	−66.9
	—	0.4	−0.1	0.0	—	—	−0.4	0.3	0.2	0.5	1.5	−4.8
Per share — as-filed variants
	−₹1.37	₹0.05	−₹10.46	−₹8.38	−₹9.11	−₹10.16	−₹8.11	−₹8.23	−₹13.10	−₹8.06	−₹7.93	−₹3.66
	−₹1.37	₹0.05	−₹10.46	−₹8.38	−₹9.11	−₹10.16	−₹8.11	−₹8.23	−₹13.10	−₹8.06	−₹7.93	−₹3.66
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	47.4	33.7	−130	−118	−127	−134	−60.8	−83.5	−182	−124	−92.3	4.9
	8.2%	8.3%	−37.3%	−39.0%	−39.4%	−47.5%	−11.2%	−28.9%	−46.7%	−36.2%	−17.2%	0.8%
Adjusted (ex-exceptional items) — derived
	−7.1	5.1	−254	−201	−216	−228	−157	−183	−267	−157	−191	−81.8
	−25.6	1.3	−191	−153	−166	−186	−149	−150	−239	−147	−144	−71.8
	−₹1.37	₹0.05	−₹10.46	−₹8.38	−₹9.11	−₹10.16	−₹8.11	−₹8.23	−₹13.10	−₹8.06	−₹7.93	−₹3.66

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

OMAXE₹97.30

Omaxe Limited

· Real Estate

Annual Quarterly₹ CrorePeersARKADE AJMERA ALEMBICLTD HUBTOWN MARATHON ARVSMART PVP AGIILMcap ₹1,780 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	599.2	535.6	341.6	389.2	288.9	541.3	282.2	320.8	301.8	348.5	406.2	575.5
Other Income	2.7	6.7	43.6	9.1	11.5	11.8	15.8	25.5	17.2	27.8	32.8	38.4
Total Income	601.9	542.3	385.2	398.3	300.4	553.0	298.0	346.4	319.0	376.3	438.9	613.9
Expenses
+ Cost of Materials Consumed	408.8	448.4	365.3	575.9	641.5	513.9	457.7	819.0	756.8	778.1	523.4	695.3
+ Changes in Inventories	185.6	179.5	100.0	-5.0	-269.1	88.2	-41.4	-371.6	-337.3	-299.4	-150.9	-167.2
+ Employee Benefit Expense	9.4	5.3	5.9	6.3	5.3	6.6	7.9	7.3	3.9	5.5	2.8	4.5
+ Finance Costs	32.4	38.2	42.4	44.6	57.0	51.3	67.0	64.7	53.9	69.5	27.1	36.6
+ Depreciation & Amortisation	14.6	13.6	7.2	7.5	10.4	11.6	7.2	8.3	9.0	10.1	7.9	9.3
+ Other Expenses	32.9	48.8	21.6	35.7	38.0	38.6	27.7	35.3	33.6	66.3	23.6	42.4
Total Expenses	683.7	733.7	542.4	665.0	483.1	710.2	526.1	562.8	519.9	630.0	433.8	621.0
EBITDA	-37.4	-146.3	-151.2	-223.7	-126.8	-106.0	-169.6	-169.1	-155.2	-201.9	7.3	0.4
EBIT	-52.0	-159.9	-158.4	-231.2	-137.2	-117.6	-176.9	-177.3	-164.2	-212.0	-0.6	-8.9
Profit
PBT before Exceptional Items	-81.8	-191.4	-157.2	-266.7	-182.7	-157.2	-228.1	-216.5	-200.8	-253.7	5.1	-7.1
Pretax Income	-81.8	-191.4	-157.2	-266.7	-182.7	-157.2	-228.1	-216.5	-200.8	-253.7	5.1	-7.1
+ Current Tax	1.5	0.3	1.4	2.1	1.8	-2.6	1.1	1.2	0.7	0.6	2.5	5.5
+ Deferred Tax	-11.4	-47.9	-11.5	-29.6	-34.2	-6.0	-43.4	-51.2	-48.3	-62.9	1.3	13.0
Tax Expense	-9.9	-47.6	-10.2	-27.5	-32.4	-8.6	-42.3	-50.0	-47.6	-62.3	3.8	18.5
+ Share of Associates & JVs	0.1	0.1	0.0	-0.2	0.0	-0.1	0.0	0.0	0.0	-0.0	0.0	0.0
Net Income	-71.8	-143.6	-147.0	-239.5	-150.3	-148.7	-185.8	-166.4	-153.2	-191.4	1.3	-25.6
+ Net Income — Continuing Ops	-71.8	-143.7	-147.0	-239.3	-150.3	-148.6	-185.8	-166.4	-153.2	-191.4	1.3	-25.6
+ Other Comprehensive Income	0.1	0.2	-1.3	0.4	0.5	0.8	0.5	0.0	-0.1	0.1	-0.3	1.2
Total Comprehensive Income	-71.7	-143.4	-148.3	-239.1	-149.8	-147.9	-185.3	-166.4	-153.3	-191.4	1.1	-24.4
Net Income to Common	—	-145.1	-147.4	-239.7	-150.6	-148.3	—	-166.6	-153.2	-191.3	0.9	—
Minority Interest	0.0	1.5	0.5	0.2	0.3	-0.4	—	0.2	0.0	-0.1	0.4	—
Per Share
Basic EPS	-3.66	-7.93	-8.06	-13.10	-8.23	-8.11	-10.16	-9.11	-8.38	-10.46	0.05	-1.37
Diluted EPS	-3.66	-7.93	-8.06	-13.10	-8.23	-8.11	-10.16	-9.11	-8.38	-10.46	0.05	-1.37
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.8	0.5	0.0	-0.1	0.1	-0.3	1.2
+ Items NOT to be Reclassified to P&L	0.1	0.3	-1.7	0.4	0.7	0.9	0.6	0.1	-0.1	0.5	-0.3	1.6
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.1	0.2	0.1	-0.0	0.5	-0.1	0.4
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.1	-0.4	0.0	0.2	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	-66.9	-144.8	-148.7	-239.2	-150.1	-147.6	—	—	-153.3	-191.3	0.6	—
Comprehensive Income — Non-controlling Interests	-4.8	1.5	0.5	0.2	0.3	-0.4	—	—	0.0	-0.1	0.4	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-3.66	-7.93	-8.06	-13.10	-8.23	-8.11	-10.16	-9.11	-8.38	-10.46	0.05	-1.37
Diluted EPS — Continuing Operations	-3.66	-7.93	-8.06	-13.10	-8.23	-8.11	-10.16	-9.11	-8.38	-10.46	0.05	-1.37
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	4.9	-92.3	-123.8	-181.8	-83.5	-60.8	-134.1	-126.6	-117.7	-130.1	33.7	47.4
Gross Margin %	0.82	-17.23	-36.23	-46.71	-28.90	-11.23	-47.51	-39.45	-39.00	-37.34	8.29	8.23
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-81.8	-191.4	-157.2	-266.7	-182.7	-157.2	-228.1	-216.5	-200.8	-253.7	5.1	-7.1
Net Income Adj (tax-effected)	-71.8	-143.6	-147.0	-239.5	-150.3	-148.7	-185.8	-166.4	-153.2	-191.4	1.3	-25.6
EPS Adj	-3.66	-7.93	-8.06	-13.10	-8.23	-8.11	-10.16	-9.11	-8.38	-10.46	0.05	-1.37
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	182.9	182.9	182.9	182.9	182.9	182.9	182.9	182.9	182.9	182.9	182.9	182.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Omaxe Q2 FY27 results (July–September 2026)

Filed with NSE on Tuesday, 27 October 2026 at 4:53 pm IST

Omaxe (NSE: OMAXE) reported its Q2 FY27 results (July–September 2026) on Tuesday, 27 October 2026 at 4:53 pm IST. Consolidated net loss was ₹25.6 crore, narrower than the loss of ₹167 crore in Q2 FY26 and against a profit of ₹90 lakh in Q1 FY27. Revenue from operations was ₹576 crore, up 79.4% year on year and up 41.7% from the previous quarter.

Q2 FY26 results (a year earlier): 14 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net loss: −₹25.6 Crloss ₹167 Cr in Q2 FY26profit ₹90 lakh in Q1 FY27
Revenue from operations: ₹576 Cr+79.4% vs Q2 FY26+41.7% vs Q1 FY27
Operating margin (EBIT): −1.5%+53.7 pts vs Q2 FY26−1.4 pts vs Q1 FY27EBIT −₹8.9 Cr
EBITDA: ₹40 lakh−₹169 Cr in Q2 FY26−94.5% vs Q1 FY27margin 0.1%
Earnings per share (basic): −₹1.37
Net profit margin: −4.4%+47.5 pts vs Q2 FY26−4.7 pts vs Q1 FY27

Questions

What was Omaxe's net profit in Q2 FY27?

Consolidated net loss was ₹25.6 crore, narrower than the loss of ₹167 crore in Q2 FY26 and against a profit of ₹90 lakh in Q1 FY27.

What was Omaxe's revenue in Q2 FY27?

Revenue from operations was ₹576 crore, up 79.4% year on year and up 41.7% from the previous quarter.

How were Omaxe's Q2 FY27 results?

A net loss of ₹25.6 crore, narrower than the loss of ₹167 crore in Q2 FY26. Revenue was up 79.4% at ₹576 crore. The operating margin was −1.5%, up 53.7 percentage points from −55.3% a year earlier.

What was Omaxe's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was −₹8.9 crore, a margin of −1.5%, against −0.1% in Q1 FY27 and −55.3% in Q2 FY26. EBITDA was ₹40 lakh, 0.1% of revenue.

What is Omaxe's net profit margin?

Omaxe's net profit margin was −4.4% in Q2 FY27 (net profit as a share of revenue from operations), against −51.9% in Q2 FY26 (up 47.5 percentage points). For FY26 as a whole it was −55.6%.

What was Omaxe's net profit in FY26?

Consolidated net profit was a loss of ₹697 crore in FY26 (April 2025–March 2026), wider than the loss of ₹686 crore in FY25. It was a loss of ₹403 crore in FY24 and a loss of ₹348 crore in FY23.

What was Omaxe's EPS in Q2 FY27?

Basic earnings per share were −₹1.37, against −₹9.11 in Q2 FY26.

What was Omaxe's revenue in FY26?

Revenue from operations was ₹1,253 crore in FY26 (April 2025–March 2026), down 19.7% from ₹1,561 crore in FY25. It was ₹1,614 crore in FY24 and ₹773 crore in FY23: up 62.1% over three years, 17.5% a year on average.

When did Omaxe announce its Q2 FY27 results?

On Tuesday, 27 October 2026 at 4:53 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 14 November 2025.

What was Omaxe's net profit in the first half of FY27?

Consolidated net loss for the first half of FY27 (April–September 2026) was ₹24.7 crore, narrower than the loss of ₹352 crore in the same months a year earlier. Revenue from operations was ₹982 crore, up 62.8%.

How has Omaxe's profit changed over the last four quarters?

Net profit by quarter: a loss of ₹153 crore in Q3 FY26, a loss of ₹191 crore in Q4 FY26, a profit of ₹90 lakh in Q1 FY27 and a loss of ₹25.6 crore in Q2 FY27. That is a combined loss of ₹369 crore over the four quarters. Revenue from operations: ₹302 crore, ₹349 crore, ₹406 crore and ₹576 crore.

When will Omaxe announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Omaxe figures come from?

From Omaxe's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.